Acknowledgement
Supported by : Korea Science and Engineering Foundation, National Research Foundation of Korea
References
- Bae, I.H., Park, M.J., Yoon, S.H., Kang, S.W., Lee, S.S., Choi, K.M., and Um, H.D. (2006). Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt and Sp1. Cancer Res. 66, 4991-4995 https://doi.org/10.1158/0008-5472.CAN-05-4254
- Cabane, C., Coldefy, A.S., Yeow, K., and Derijard, B. (2004). The p38 pathway regulates Akt both at the protein and transcriptional activation levels during myogenesis. Cell. Signal. 16, 1405-1415 https://doi.org/10.1016/j.cellsig.2004.05.003
- Castagna, A., Antonioli, P., Astner, H., Hamdan, M., Rlghetti, S.C., Perego, P., Zunino, F., and Righetti, P.G. (2004). A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. Proteomics 4, 3246-3267 https://doi.org/10.1002/pmic.200400835
- Chang, X.Z., Li, D.Q., Hou, Y.F., Wu, J., Lu, J.S., Di, G.H., Jin, W., Ou, Z.L., Shen, Z.Z., and Shao, Z.M. (2007). Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res. 9, R76
- Chen, W.C., McBride, W.H., Iwamoto, K.S., Barber, C.L., Wan, C.C., Oh, Y.T., Liao, Y.P., Hong, J.H., De Vellis, J., and Shau, H. (2002). Induction of radioprotective peroxiredoxin-ІІ by ionizing irradiation. J. Neurosci. Res. 70, 794-798 https://doi.org/10.1002/jnr.10435
- Chung, Y.M., Yoo, Y.D., Park, J.K., Kim, Y.T., and Kim, H.J. (2001). Increased expression of peroxiredoxin confers resistance to cisplatin. Anticancer Res. 21, 1129-1133
- Duffy, M.J. (2002). Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers. Biochem. Soc. Trans. 30, 207-210 https://doi.org/10.1042/BST0300207
- Egeblad, M., and Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174 https://doi.org/10.1038/nrc745
- Huang, C., Jacobson, K., and Schaller, M.D. (2004). MAP kinase and cell migration. J. Cell Sci. 117, 4619-4628 https://doi.org/10.1242/jcs.01481
- Immenschuh, S., and Baumgart-Vogt, E. (2005). Peroxiredoxins, oxidative stress, and cell proliferation. Anntioxid. Redox. Signal. 7, 768-777 https://doi.org/10.1089/ars.2005.7.768
- Jiang, B.H., and Liu, L.Z. (2008). PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim. Biophys. Acta 1784, 150-158 https://doi.org/10.1016/j.bbapap.2007.09.008
- Karihtala, P., Mantyniemi, A., Kang, S.W., Kinnula, V.L., and Soini, Y. (2003). Peroxiredoxins in breast carcinoma. Clin. Cancer Res. 9, 3418-3424
- Kim, D.K., Cho, E.S., Seong, J.K., and Um, H.D. (2001). Adaptive concentrations of hydrogen peroxide suppress cell death by blocking the activation of SAPK/JNK pathway. J. Cell Sci. 114, 4329-4334
- Kim, J.H., Bogner, P.N., Ramnath, N., Park, Y., Yu, J., and Park, Y.M. (2007). Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer. Clin. Cacner Res. 13, 3875-3882 https://doi.org/10.1158/1078-0432.CCR-06-2893
- Kinnula, V.L., Lehtonen, S., Sormunen, R., Kaarteenaho-Wiik, R., Kang, S.W., Rhee, S.G., and Soini, Y. (2002). Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J. Pathol. 196, 316-323 https://doi.org/10.1002/path.1042
- Kropotov, A., Gogvadze, V., Shupliakov, O., Tomilin, N., Serikov, V.B., Tomilin, N.V., and Zhivotovsky, B. (2006). Peroxiredoxin V is essential for protection against apoptosis in human lung carcinoma cells. Exp. Cell Res. 312, 2806-2815 https://doi.org/10.1016/j.yexcr.2006.05.006
- Lee, J.B., Yun, S.J., Chae, H.Z., Won, Y.H., Kim, Y.P., and Lee, S.C. (2002). Expression of peroxiredoxin and thioredoxin in dermatological disorders. Br. J. Dermatol. 146, 710-712 https://doi.org/10.1046/j.1365-2133.2002.46845.x
- Lee, T.H., Kim, S.U., Yu, S.L., Kim, S.H., Park, D.S., Moon, H.B., Dho, S.H., Kwon, K.S., Kwon, H.J., Han, Y.H., et al. (2003). Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 101, 5033-5038 https://doi.org/10.1182/blood-2002-08-2548
- Lee, S.B., Cho, E.S., Yang, H.S., Kim, H., and Um, H.D. (2005a). Serum withdrawal kills U937 cells by inducing a positive mutual interaction between reactive oxygen species and phosphoinositide 3-kinase. Cell. Signal. 17, 197-204 https://doi.org/10.1016/j.cellsig.2004.07.001
- Lee, S.B., Hong, S.H., Kim, H., and Um, H.D. (2005b). Co-induction of cell death and survival pathways by phosphoinositide 3- kinase. Life Sci. 78, 91-98 https://doi.org/10.1016/j.lfs.2005.04.035
- Lehtonen, S.T., Svensk, A.M., Soini, Y., Paakko, P., Hirvikoski, P., Kang, S.W., Saily, M., and Kinnula, V.L. (2004). Peroxiredoxins, a novel protein family in lung cancer. Int. J. Cancer 111, 514- 521 https://doi.org/10.1002/ijc.20294
- Li, D.Q., Wang, L., Fei, F., Hou, Y.F., Luo, J.M., Wei-Chen, Zeng R., Wu, J., Lu, J.S., Di, G.H., Ou, Z.L., et al. (2006). Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Pro-teomics 6, 3352-3368 https://doi.org/10.1002/pmic.200500617
- Neumann, C.A., Krause, D.S., Carman, C.V., Das, S., Dubey, D.P., Abraham, J.L., Bronson, R.T., Fujiwara, Y., Orkin, S.H., and Van Etten, R.A. (2003). Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424, 561-565 https://doi.org/10.1038/nature01819
- Orlichenko, L.S., and Radisky, D.C. (2008). Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin. Exp. Metastasis 25, 593-600 https://doi.org/10.1007/s10585-008-9143-9
- Park, S.H., Chung, Y.M., Lee, Y.S., Kim, H.J., Kim, J.S., Chae, H.Z., and Yoo, Y.D. (2000). Antisense of human peroxiredoxin II enhances radiation-induced cell death. Clin. Cancer Res. 6, 4915-4920
- Park, M.T., Choi, J.A., Kim, M.J., Um, H.D., Bae, S., Kang, C.M., Cho, C.K., Kang, S., Chung, H.Y., Lee, Y.S., et al. (2003). Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells. J. Biol. Chem. 278, 50624-50634
- Park, D., Shim, E., Kim, Y., Kim, Y.M., Lee, H., Choe, J., Kang, D., Lee, Y.S., and Jeoung, D. (2008). C-FLIP promotes the motility of cancer cells by activating FAK and ERK, and increasing MMP-9 expression. Mol. Cells 25, 184-195
- Rane, M.J., Coxon, P.Y., Powell, D.W., Webster, R., Klein, J.B., Pierce, W., Ping, P., and McLeish, K.R. (2001). p38 Kinasedependent MAPKAPK-2 activation functions as 3-phosphoinositide- dependent kinase-2 for Akt in human neutrophils. J. Biol. Chem. 276, 3517-3523 https://doi.org/10.1074/jbc.M005953200
- Reddy, K.B., Nabha, S.M., and Atanaskova, N. (2003). Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev. 22, 395-403 https://doi.org/10.1023/A:1023781114568
- Rhee, S.G., Kang, S.W., Chang, T.S., Jeong, W., and Kim, K. (2001). Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52, 35-41 https://doi.org/10.1080/15216540252774748
- Rhee, S.G., Chae, H.Z., and Kim, K. (2005). Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38, 1543-1552 https://doi.org/10.1016/j.freeradbiomed.2005.02.026
- Samuels, Y., and Ericson, K. (2006). Oncogenic PI3K and its role in cancer. Curr. Opin. Oncol. 18, 77-82 https://doi.org/10.1097/01.cco.0000198021.99347.b9
- Smith, L., Welham, K.J., Watson, M.B., Drew, P.J., Lind, M.J., and Cawkwell, L. (2007). The proteomic analysis of cisplatin resistance in breast cancer cells. Oncol. Res. 16, 497-506 https://doi.org/10.3727/096504007783438358
- Wang, X., Phelan, S.A., Forsman-Semb, K., Taylor, E.F., Petros, C., Brown, A., Lerner, C.P., and Paigen, B. (2003). Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress. J. Biol. Chem. 278, 25179-25190 https://doi.org/10.1074/jbc.M302706200
- Wang, Y., Feinstein, S.I., Manevich, Y., Ho, Y.S., and Fisher, A.B. (2006). Peroxiredoxin 6 gene-targeted mice show increased lung injury with paraquat-induced oxidative stress. Antioxid. Redox. Signal. 8, 229-237 https://doi.org/10.1089/ars.2006.8.229
-
Wang, Y., Feinstein, S.I., and Fisher, A.B. (2008). Peroxiredoxin 6 as an antioxidant enzyme: protection of lung alveolar epithelial type II cells from
$H_2O_2$ -induced oxidative stress. J. Cell. Biochem. 104, 1274-1285 https://doi.org/10.1002/jcb.21703 - Wood, Z.A., Schroder, E., Harri, J.R., and Poole, L.B. (2003). Structure, mechanism and regulation of peroxiredoxins. Trend Biochem. Sci. 28, 32-40 https://doi.org/10.1016/S0968-0004(02)00003-8
- Yanagawa, T., Ishikawa, T., Ishii, T., Tabuchi, K., Iwasa, S., Bannai, S., Omura, K., Suzuki, H., and Yoshida, H. (1999). Peroxiredoxin I expression in human thyroid tumors. Cancer Lett. 145, 127-132 https://doi.org/10.1016/S0304-3835(99)00243-8
- Zhang, Q.S., Maddock, D.A., Chen, J.P., Heo, S., Chiu, C., Lai, D., Souza, K., Mehta, S., and Wan, Y.S. (2001). Cytokine-induced p38 activation feedback regulates the prolonged activation of Akt cell survival pathway initiated by reactive oxygen species in response to UV irradiation in human keratinocytes. Int. J. Oncol. 19, 1057-1061
Cited by
- Phospholipase A2 Activity of Peroxiredoxin 6 Promotes Invasion and Metastasis of Lung Cancer Cells vol.9, pp.4, 2010, https://doi.org/10.1158/1535-7163.mct-09-0904
- Peroxiredoxin 6 differentially regulates acute and chronic cigarette smoke-mediated lung inflammatory response and injury vol.36, pp.8, 2009, https://doi.org/10.3109/01902141003754128
- Rapid Verification of Candidate Serological Biomarkers Using Gel-based, Label-free Multiple Reaction Monitoring vol.10, pp.9, 2009, https://doi.org/10.1021/pr2002098
- Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer vol.137, pp.8, 2009, https://doi.org/10.1007/s00432-011-0992-2
- Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches vol.2012, pp.None, 2009, https://doi.org/10.1155/2012/425636
- A Xenograft Mouse Model Coupled with In-depth Plasma Proteome Analysis Facilitates Identification of Novel Serum Biomarkers for Human Ovarian Cancer vol.11, pp.2, 2009, https://doi.org/10.1021/pr200603h
- Pharmacological antioxidant strategies as therapeutic interventions for COPD vol.1822, pp.5, 2009, https://doi.org/10.1016/j.bbadis.2011.11.004
- Curcumin abates hypoxia-induced oxidative stress based-ER stress-mediated cell death in mouse hippocampal cells (HT22) by controlling Prdx6 and NF-κB regulation vol.304, pp.7, 2009, https://doi.org/10.1152/ajpcell.00345.2012
- Protective Effects of Andrographolide Analogue AL-1 on ROS-Induced RIN-mβ Cell Death by Inducing ROS Generation vol.8, pp.6, 2013, https://doi.org/10.1371/journal.pone.0063656
- Nicotine-induced upregulation of antioxidant protein Prx 1 in oral squamous cell carcinoma vol.58, pp.16, 2013, https://doi.org/10.1007/s11434-013-5779-1
- Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells vol.8, pp.None, 2009, https://doi.org/10.3389/fncel.2014.00214
- Anti-Cancer Effect of Thiacremonone through Down Regulation of Peroxiredoxin 6 vol.9, pp.3, 2009, https://doi.org/10.1371/journal.pone.0091508
- Preparation and antitumor effect of a toxin-linked conjugate targeting vascular endothelial growth factor receptor and urokinase plasminogen activator vol.240, pp.2, 2009, https://doi.org/10.1177/1535370214547154
- Peroxiredoxin 6 triggers melanoma cell growth by increasing arachidonic acid-dependent lipid signalling vol.471, pp.2, 2015, https://doi.org/10.1042/bj20141204
- Epigenetic regulation of peroxiredoxins: Implications in the pathogenesis of cancer vol.242, pp.2, 2009, https://doi.org/10.1177/1535370216669834
- Prognostic roles of mRNA expression of peroxiredoxins in lung cancer vol.11, pp.None, 2009, https://doi.org/10.2147/ott.s181314
- Peroxiredoxins in Cancer and Response to Radiation Therapies vol.8, pp.1, 2009, https://doi.org/10.3390/antiox8010011
- Overexpression and biological function of PRDX6 in human cervical cancer vol.11, pp.9, 2009, https://doi.org/10.7150/jca.39892
- Proteomic analysis of extracellular vesicles identified PI3K pathway as a potential therapeutic target for cabazitaxel‐resistant prostate cancer vol.81, pp.9, 2009, https://doi.org/10.1002/pros.24138